Literature DB >> 12006411

Production of the long pentraxin PTX3 in advanced atherosclerotic plaques.

Michael S Rolph1, Sabine Zimmer, Barbara Bottazzi, Cecilia Garlanda, Alberto Mantovani, Göran K Hansson.   

Abstract

Elevated plasma levels of the pentraxin protein family member C-reactive protein (CRP) are associated with increased risk of cardiovascular disease in both healthy and high-risk subjects. The long pentraxin family member, pentraxin 3 (PTX3), was recently described. Like CRP, PTX3 is induced by acute inflammatory stimuli and is increased in the blood of patients with acute myocardial infarction. Unlike CRP, it is expressed in a wide range of cell types, but not in hepatocytes. In this study, we have investigated the expression of PTX3 in atherosclerosis. Immunohistochemical staining of advanced atherosclerotic lesions revealed strong expression of PTX3. In contrast, no PTX3 expression was observed in nonatherosclerotic internal mammary arteries. By staining serial sections with cell type- and PTX3-specific antibodies, we observed that PTX3 was produced principally by macrophages and endothelial cells. Infrequent expression by smooth muscle cells was also observed. Our results suggest that PTX3 may contribute to the pathogenesis of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12006411     DOI: 10.1161/01.atv.0000015595.95497.2f

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  84 in total

1.  Effects of telmisartan on markers of ventricular remodeling in patients with acute myocardial infarction: comparison with enalapril.

Authors:  Takashi Yokota; Tomohiro Osanai; Kenji Hanada; Motoi Kushibiki; Naoki Abe; Koichi Oikawa; Hirofumi Tomita; Takumi Higuma; Jin Yokoyama; Hiroyuki Hanada; Ken Okumura
Journal:  Heart Vessels       Date:  2010-10-05       Impact factor: 2.037

2.  Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Ruth Dubin; Michael Shlipak; Yongmei Li; Joachim Ix; Ian H de Boer; Nancy Jenny; Carmen A Peralta
Journal:  Nephrol Dial Transplant       Date:  2010-11-15       Impact factor: 5.992

3.  Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study.

Authors:  Ruth Dubin; Yongmei Li; Joachim H Ix; Michael G Shlipak; Mary Whooley; Carmen A Peralta
Journal:  Am Heart J       Date:  2012-02       Impact factor: 4.749

4.  Differential associations of serum amyloid A and pentraxin-3 with allele-specific lipoprotein(a) levels in African Americans and Caucasians.

Authors:  Byambaa Enkhmaa; Erdembileg Anuurad; Zeynep Ozturk; Wei Zhang; Thomas A Pearson; Lars Berglund
Journal:  Transl Res       Date:  2011-02-05       Impact factor: 7.012

5.  Advanced glycation endproduct-induced aging of the retinal pigment epithelium and choroid: a comprehensive transcriptional response.

Authors:  Jane Tian; Kazuki Ishibashi; Kazuko Ishibashi; Karen Reiser; Rhonda Grebe; Shyam Biswal; Peter Gehlbach; James T Handa
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-04       Impact factor: 11.205

6.  Circulating pentraxin 3 levels are higher in metabolic syndrome with subclinical atherosclerosis: evidence for association with atherogenic lipid profile.

Authors:  Michela Zanetti; Alessandra Bosutti; Clara Ferreira; Pierandrea Vinci; Gianni Biolo; Maurizio Fonda; Matteo Valente; Luigi Cattin; Gianfranco Guarnieri; Rocco Barazzoni
Journal:  Clin Exp Med       Date:  2009-02-24       Impact factor: 3.984

7.  Shenfu Injection suppresses inflammation by targeting haptoglobin and pentraxin 3 in rats with chronic ischemic heart failure.

Authors:  Si-Dao Zheng; Hong-Jin Wu; Shao-Ping Yu; Jian-Xun Ren; Wei-Wei Duo; Zeng-Chun Ma; Yue Gao; Sheng-Qi Wang; Yu-Na Liu
Journal:  Chin J Integr Med       Date:  2013-03-15       Impact factor: 1.978

8.  Aerobic fitness alters the capacity of mononuclear cells to produce pentraxin 3 following maximal exercise.

Authors:  Aaron L Slusher; Tiffany M Zúñiga; Edmund O Acevedo
Journal:  Eur J Appl Physiol       Date:  2018-05-10       Impact factor: 3.078

9.  Pentraxin 3 as a novel marker predicting congestive heart failure in subjects with acute coronary syndrome.

Authors:  Dong-Hyeon Lee; Hui-Kyung Jeon; Ji-Han You; Mi-Yeon Park; Seung-Jae Lee; Sung-Sik Kim; Byung-Joo Shim; Yun-Seok Choi; Woo-Seung Shin; Jong-Min Lee; Chul-Soo Park; Ho-Joong Youn; Wook-Sung Chung; Jae-Hyung Kim
Journal:  Korean Circ J       Date:  2010-08-31       Impact factor: 3.243

10.  Comparison of markers of oxidative stress, inflammation and arterial stiffness between incident hemodialysis and peritoneal dialysis patients--an observational study.

Authors:  Robert G Fassett; Ritza Driver; Helen Healy; Dwarakanathan Ranganathan; Sharad Ratanjee; Iain K Robertson; Dominic P Geraghty; James E Sharman; Jeff S Coombes
Journal:  BMC Nephrol       Date:  2009-03-12       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.